Clincosm LogoSign in Get a demo

Chronic Lymphocytic Leukemia

Showing NaN - NaN of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Tucson, Arizona
  • +9 more
Feb 10, 2022

Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)

Active, not recruiting
Has Results
  • Leukemia
  • +2 more
  • Duarte, California
  • +45 more
Jan 27, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +12 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +2 more
Feb 17, 2022

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • autologous or syngeneic PBTLs and EBV-CTLs
  • Houston, Texas
  • +1 more
Feb 6, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Questionnaire Administration
  • Ruxolitinib Phosphate
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +14 more
Dec 29, 2021

Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +2 more
  • ABT-199 (Main Cohort)
  • ABT-199 (Safety Expansion Cohort)
  • Tucson, Arizona
  • +47 more
Nov 19, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Little Rock, Arkansas
  • +144 more
Dec 3, 2021

B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)

Recruiting
  • B-cell Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • XmAb13676
  • La Jolla, California
  • +21 more
Oct 20, 2021

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in United States (hLL1-DOX (IMMU-115))

Terminated
  • Non-Hodgkin's Lymphoma
  • Chronic Lymphocytic Leukemia
  • hLL1-DOX (IMMU-115)
  • Newark, Delaware
  • +5 more
Oct 6, 2021

Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

Completed
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +16 more
Oct 4, 2021

Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Rituximab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 11, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Post-Chlorambucil Therapy Follow-up
  • +4 more
  • Duarte, California
  • +106 more
Aug 6, 2021

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2021

Chronic Lymphocytic Leukemia, Peripheral T-cell Lymphoma Trial in United States (20 mg/kg TRU-016 + Rituximab, 10 mg/kg TRU-016

Terminated
  • Chronic Lymphocytic Leukemia
  • Peripheral T-cell Lymphoma
  • 20 mg/kg TRU-016 + Rituximab
  • +5 more
  • Augusta, Georgia
  • +7 more
May 18, 2021

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Educational Intervention, Questionnaire Administration,

Recruiting
  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia
  • Educational Intervention
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2021

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

Terminated
  • Chronic Lymphocytic Leukemia
  • +7 more
  • Orange, California
  • +10 more
Oct 15, 2020

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

Leukemia, Chronic Lymphocytic Leukemia, Lymphocytic Leukemia Trial in Houston (Lirilumab, Rituximab)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 26, 2020

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Completed
  • Chronic Lymphocytic Leukemia
    • Pomona, California
    • +164 more
    May 8, 2020